Supply Chain Ecosystem Analysis now part of DBMR Reports
Market Size in USD Billion
| 2023 –2030 | |
|
|
USD 9,200.00 Million |
| USD 14,998.71 Million | |
| % | |
|
Global Large Volume Parenteral Market, By Type (Soft Bag LVP, Plastic Bottle LVP, Glass Bottle LVP), Volume (100 ml-250 ml, 250 ml-500 ml, 500 ml-1000 ml, 1000 ml-2000 ml, 2000 ml and more), Application (Therapeutic Injections, Fluid Balance Injections, Nutritious Injections), End-Users (Clinic, Hospital, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) - Industry Trends and Forecast to 2030.
Get Exclusive Sample Copy of this Report Here
The global large volume parenteral market is rising steadily due to regulatory requirements. Growing R&D activities is considerably driving the global large volume parenteral market. Strategic initiatives by the key market players are one of the elements driving the market's rapid rise. Market players are expanding their product offerings to acquire a competitive advantage.
Data Bridge Market Research analyses that the global large volume parenteral market which was USD 9,200.00 Million in 2022, would rocket up to USD 14,998.71 Million by 2030 and is expected to undergo a CAGR of 6.3% during the forecast period. "Soft bag" dominates the type segment of the global large volume parenteral market owing to the increasing investment in healthcare. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015-2020)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Type (Soft Bag LVP, Plastic Bottle LVP, Glass Bottle LVP), Volume (100 ml-250 ml, 250 ml-500 ml, 500 ml-1000 ml, 1000 ml-2000 ml, 2000 ml, and more), Application (Therapeutic Injections, Fluid Balance Injections, Nutritious Injections), End-Users (Clinic, Hospital, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy)
|
|
Countries Covered
|
U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa
|
|
Market Players Covered
|
Teva Pharmaceutical Industries Ltd. (Israel), Pfizer Inc. (U.S.), Otsuka America Pharmaceutical, Inc. (U.S.), Sichuan KELUN PHARMACEUTICAL Co., Ltd.(China), Cook Pharmica LLC.(U.S.), Thermo Fisher Scientific Inc. (U.S.), BAG Health Care GmbH (Germany), Baxter (U.S.), WOCKHARDT (India), Southwest Pharmaceutical Co. Ltd. (China)
|
|
Market Opportunities
|
|
Market Definition
The global Large Volume Parenteral (LVP) market is for intravenous solutions or fluids administered in large volumes to patients. LVPs are sterile solutions typically provided in containers such as bottles or bags. These solutions are used for various medical purposes, including fluid and electrolyte replacement, nutritional support, medication administration, and other therapeutic interventions.
Drivers
The rising incidence of chronic diseases such as cancer, diabetes, and cardiovascular disorders has led to a growing demand for LVP products, often used for administering medications in these conditions.
The development of innovative manufacturing techniques, such as aseptic filling systems and advanced filtration technologies, has improved the safety, sterility, and efficiency of LVP production. These technological advancements have boosted market growth.
Opportunities
Expansion of home healthcare
The trend towards home-based healthcare services provides opportunities for the LVP market. Patients receiving long-term intravenous therapies may opt for home healthcare, increasing the demand for LVP products outside traditional hospital settings.
Furthermore, the rising collaboration, merger, and acquisition among the market players will extend profitable opportunities for the market players in the forecast period of 2023 to 2030. In addition, the rising number of market players will further expand the market's growth rate in the future.
Restraint/Challenge
The high cost associated with product manufacturing is expected to obstruct market growth. Also, the supply chain industry disruption can challenge the market's growth. In addition, the lack of a favorable reimbursement scenario, technology penetration in the developing economies, and lack of suitable infrastructure are projected to challenge the market in the forecast period of 2023-2030.
This global large volume parenteral report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global large volume parenteral market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Developments
The global large volume parenteral market is segmented based on type, volume, application, end-users, and distribution channel. The growth amongst these segments will help you analyse meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Type
Volume
Application
End-Users
Distribution Channel
Global large volume parenteral market is analyzed, and market size insights and trends are provided by type, volume, application, end-users, and distribution channel, as referenced above.
The countries covered in the global large volume parenteral market report are U.S., Canada, Mexico, Brazil, Argentina, Peru, rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, and rest of Middle East and Africa.
North America dominates the market due to rising healthcare costs, increased R&D, and trending technological advancements.
Asia-Pacific is expected to witness the fastest growth during the forecast period of 2023 to 2030 because of the rising strategic initiatives by the key market players and favorable government initiatives in the region.
The country section of the report also provides individual market impacting factors and changes in market regulation that impact the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of Europe brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The large volume parenteral market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for large volume parenteral market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the the market. The data is available for historic period 2015-2020.
The large volume parenteral market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to the market.
Some of the major players operating in the large volume parenteral market are:
SKU-
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF GLOBAL LARGE VOLUME PARENTERAL MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATION
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 KEY TAKEAWAYS
2.2 ARRIVING AT THE GLOBAL XX SIZE
2.2.1 VENDOR POSITIONING GRID
2.2.2 TECHNOLOGY LIFE LINE CURVE
2.2.3 TRIPOD DATA VALIDATION MODEL
2.2.4 MARKET GUIDE
2.2.5 MULTIVARIATE MODELLING
2.2.6 TOP TO BOTTOM ANALYSIS
2.2.7 CHALLENGE MATRIX
2.2.8 APPLICATION COVERAGE GRID
2.2.9 STANDARDS OF MEASUREMENT
2.2.10 VENDOR SHARE ANALYSIS
2.2.11 DATA POINTS FROM KEY PRIMARY INTERVIEWS
2.2.12 DATA POINTS FROM KEY SECONDARY DATABASES
2.3 GLOBAL LARGE VOLUME PARENTERAL MARKET: RESEARCH SNAPSHOT
2.4 ASSUMPTIONS
3 MARKET OVERVIEW
3.1 DRIVERS
3.2 RESTRAINTS
3.3 OPPORTUNITIES
3.4 CHALLENGES
4 EXECUTIVE SUMMARY
5 PREMIUM INSIGHTS
5.1 PESTEL ANALYSIS
5.2 PORTER’S FIVE FORCES MODEL
6 INDUSTRY INSIGHTS
6.1 MICRO AND MACRO ECONOMIC FACTORS
6.2 PENETRATION AND GROWTH PROSPECT MAPPING
6.3 KEY PRICING STRATEGIES
6.4 INTERVIEWS WITH SPECIALIST
6.5 ANALYIS AND RECOMMENDATION
7 INTELLECTUAL PROPERTY (IP) PORTFOLIO
7.1 PATENT QUALITY AND STRENGTH
7.2 PATENT FAMILIES
7.3 LICENSING AND COLLABORATIONS
7.4 COMPETITIVE LANDSCAPE
7.5 IP STRATEGY AND MANAGEMENT
7.6 OTHER
8 COST ANALYSIS BREAKDOWN
9 TECHNONLOGY ROADMAP
10 INNOVATION TRACKER AND STRATEGIC ANALYSIS
10.1 MAJOR DEALS AND STRATEGIC ALLIANCES ANALYSIS
10.1.1 JOINT VENTURES
10.1.2 MERGERS AND ACQUISITIONS
10.1.3 LICENSING AND PARTNERSHIP
10.1.4 TECHNOLOGY COLLABORATIONS
10.1.5 STRATEGIC DIVESTMENTS
10.2 NUMBER OF PRODUCTS IN DEVELOPMENT
10.3 STAGE OF DEVELOPMENT
10.4 TIMELINES AND MILESTONES
10.5 INNOVATION STRATEGIES AND METHODOLOGIES
10.6 RISK ASSESSMENT AND MITIGATION
10.7 FUTURE OUTLOOK
11 REGULATORY COMPLIANCE
11.1 REGULATORY AUTHORITIES
11.2 REGULATORY CLASSIFICATIONS
11.2.1 CLASS I
11.2.2 CLASS II
11.2.3 CLASS III
11.3 REGULATORY SUBMISSIONS
11.4 INTERNATIONAL HARMONIZATION
11.5 COMPLIANCE AND QUALITY MANAGEMENT SYSTEMS
11.6 REGULATORY CHALLENGES AND STRATEGIES
12 REIMBURSEMENT FRAMEWORK
13 OPPUTUNITY MAP ANALYSIS
14 INSTALLED BASE DATA
15 VALUE CHAIN ANALYSIS
16 HEALTHCARE ECONOMY
16.1 HEALTHCARE EXPENDITURE
16.2 CAPITAL EXPENDITURE
16.3 CAPEX TRENDS
16.4 CAPEX ALLOCATION
16.5 FUNDING SOURCES
16.6 INDUSTRY BENCHMARKS
16.7 GDP RATION IN OVERALL GDP
16.8 HEALTHCARE SYSTEM STRUCTURE
16.9 GOVERNMENT POLICIES
16.1 ECONOMIC DEVELOPMENT
17 GLOBAL LARGE VOLUME PARENTERAL MARKET, BY TYPE
17.1 OVERVIEW
17.2 SOFT BAG LVP
17.2.1 BY VOLUME
17.2.1.1. 100 ML-250 ML
17.2.1.2. 250 ML-500 ML
17.2.1.3. 500 ML-1000 ML
17.2.1.4. 1000 ML-2000 ML
17.2.1.5. 2000 ML AND MORE
17.3 PLASTIC BOTTLE LVP
17.3.1 BY VOLUME
17.3.1.1. 100 ML-250 ML
17.3.1.2. 250 ML-500 ML
17.3.1.3. 500 ML-1000 ML
17.3.1.4. 1000 ML-2000 ML
17.3.1.5. 2000 ML AND MORE
17.4 GLASS BOTTLE LVP
17.4.1 BY VOLUME
17.4.1.1. 100 ML-250 ML
17.4.1.2. 250 ML-500 ML
17.4.1.3. 500 ML-1000 ML
17.4.1.4. 1000 ML-2000 ML
17.4.1.5. 2000 ML AND MORE
18 GLOBAL LARGE VOLUME PARENTERAL MARKET, BY ROUTE OF ADMINISTRATION
18.1 OVERVIEW
18.2 INTRAVENOUS
18.3 INTRAPERITONEAL
18.4 SUBCUTANEOUS
18.5 OTHERS
19 GLOBAL LARGE VOLUME PARENTERAL MARKET, BY VOLUME
19.1 OVERVIEW
19.2 100 ML-250 ML
19.3 250 ML-500 ML
19.4 500 ML-1000 ML
19.5 1000 ML-2000 ML
19.6 2000 ML AND MORE
20 GLOBAL LARGE VOLUME PARENTERAL MARKET, BY APPLICATION
20.1 OVERVIEW
20.2 THERAPEUTIC INJECTIONS
20.2.1 100 ML-250 ML
20.2.2 250 ML-500 ML
20.2.3 500 ML-1000 ML
20.2.4 1000 ML-2000 ML
20.2.5 2000 ML AND MORE
20.3 FLUID BALANCE INJECTIONS
20.3.1 100 ML-250 ML
20.3.2 250 ML-500 ML
20.3.3 500 ML-1000 ML
20.3.4 1000 ML-2000 ML
20.3.5 2000 ML AND MORE
20.4 NUTRITIOUS INJECTIONS
20.4.1 100 ML-250 ML
20.4.2 250 ML-500 ML
20.4.3 500 ML-1000 ML
20.4.4 1000 ML-2000 ML
20.4.5 2000 ML AND MORE
20.5 PLASMA SUBSTITUTES
20.5.1 100 ML-250 ML
20.5.2 250 ML-500 ML
20.5.3 500 ML-1000 ML
20.5.4 1000 ML-2000 ML
20.5.5 2000 ML AND MORE
20.6 OTHERS
21 GLOBAL LARGE VOLUME PARENTERAL MARKET, BY END USER
21.1 OVERVIEW
21.2 HOSPITALS
21.2.1 PUBLIC
21.2.2 PRIVATE
21.3 SPECIALTY CLINICS
21.4 AMBULATORY CENTERS
21.5 OTHERS
22 EUROPE LARGE VOLUME PARENTERAL MARKET, BY DISTRIBUTION CHANNEL
22.1 OVERVIEW
22.2 DIRECT TENDER
22.3 RETAIL SALES
22.3.1 HOSPITAL PHARMACY
22.3.2 RETAIL PHARMCY
22.3.3 OTHERS
22.4 OTHERS
23 GLOBAL LARGE VOLUME PARENTERAL MARKET, SWOT AND DBMR ANALYSIS
24 GLOBAL LARGE VOLUME PARENTERAL MARKET, COMPANY LANDSCAPE
24.1 COMPANY SHARE ANALYSIS: GLOBAL
24.2 COMPANY SHARE ANALYSIS: NORTH AMERICA
24.3 COMPANY SHARE ANALYSIS: EUROPE
24.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
24.5 MERGERS & ACQUISITIONS
24.6 NEW PRODUCT DEVELOPMENT & APPROVALS
24.7 EXPANSIONS
24.8 REGULATORY CHANGES
24.9 PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS
25 GLOBAL LARGE VOLUME PARENTERAL MARKET, BY REGION
GLOBAL LARGE VOLUME PARENTERAL MARKET, (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)
25.1 NORTH AMERICA
25.1.1 U.S.
25.1.2 CANADA
25.1.3 MEXICO
25.2 EUROPE
25.2.1 GERMANY
25.2.2 U.K.
25.2.3 ITALY
25.2.4 FRANCE
25.2.5 SPAIN
25.2.6 RUSSIA
25.2.7 SWITZERLAND
25.2.8 TURKEY
25.2.9 BELGIUM
25.2.10 NETHERLANDS
25.2.11 DENMARK
25.2.12 SWEDEN
25.2.13 POLAND
25.2.14 NORWAY
25.2.15 FINLAND
25.2.16 REST OF EUROPE
25.3 ASIA-PACIFIC
25.3.1 JAPAN
25.3.2 CHINA
25.3.3 SOUTH KOREA
25.3.4 INDIA
25.3.5 SINGAPORE
25.3.6 THAILAND
25.3.7 INDONESIA
25.3.8 MALAYSIA
25.3.9 PHILIPPINES
25.3.10 AUSTRALIA
25.3.11 NEW ZEALAND
25.3.12 VIETNAM
25.3.13 TAIWAN
25.3.14 REST OF ASIA-PACIFIC
25.4 SOUTH AMERICA
25.4.1 BRAZIL
25.4.2 ARGENTINA
25.4.3 REST OF SOUTH AMERICA
25.5 MIDDLE EAST AND AFRICA
25.5.1 SOUTH AFRICA
25.5.2 EGYPT
25.5.3 BAHRAIN
25.5.4 UNITED ARAB EMIRATES
25.5.5 KUWAIT
25.5.6 OMAN
25.5.7 QATAR
25.5.8 SAUDI ARABIA
25.5.9 REST OF MEA
25.6 KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES
26 GLOBAL LARGE VOLUME PARENTERAL MARKET, COMPANY PROFILE
26.1 BML PARENTERAL DRUGS
26.1.1 COMPANY OVERVIEW
26.1.2 REVENUE ANALYSIS
26.1.3 GEOGRAPHIC PRESENCE
26.1.4 PRODUCT PORTFOLIO
26.1.5 RECENT DEVELOPMENTS
26.2 RUSOMA LABORATORIES PRIVATE LIMITED
26.2.1 COMPANY OVERVIEW
26.2.2 REVENUE ANALYSIS
26.2.3 GEOGRAPHIC PRESENCE
26.2.4 PRODUCT PORTFOLIO
26.2.5 RECENT DEVELOPMENTS
26.3 B. BRAUN SE
26.3.1 COMPANY OVERVIEW
26.3.2 REVENUE ANALYSIS
26.3.3 GEOGRAPHIC PRESENCE
26.3.4 PRODUCT PORTFOLIO
26.3.5 RECENT DEVELOPMENTS
26.4 HIGGS HEALTHCARE
26.4.1 COMPANY OVERVIEW
26.4.2 REVENUE ANALYSIS
26.4.3 GEOGRAPHIC PRESENCE
26.4.4 PRODUCT PORTFOLIO
26.4.5 RECENT DEVELOPMENTS
26.5 TAJ PHARMA INDIA
26.5.1 COMPANY OVERVIEW
26.5.2 REVENUE ANALYSIS
26.5.3 GEOGRAPHIC PRESENCE
26.5.4 PRODUCT PORTFOLIO
26.5.5 RECENT DEVELOPMENTS
26.6 SICHUAN KELUN PHARMACEUTICAL CO., LTD.
26.6.1 COMPANY OVERVIEW
26.6.2 REVENUE ANALYSIS
26.6.3 GEOGRAPHIC PRESENCE
26.6.4 PRODUCT PORTFOLIO
26.6.5 RECENT DEVELOPMENTS
26.7 WEILER ENGINEERING, INC.
26.7.1 COMPANY OVERVIEW
26.7.2 REVENUE ANALYSIS
26.7.3 GEOGRAPHIC PRESENCE
26.7.4 PRODUCT PORTFOLIO
26.7.5 RECENT DEVELOPMENTS
26.8 FLAGSHIP
26.8.1 COMPANY OVERVIEW
26.8.2 REVENUE ANALYSIS
26.8.3 GEOGRAPHIC PRESENCE
26.8.4 PRODUCT PORTFOLIO
26.8.5 RECENT DEVELOPMENTS
26.9 ALBERT DAVID LTD.
26.9.1 COMPANY OVERVIEW
26.9.2 REVENUE ANALYSIS
26.9.3 GEOGRAPHIC PRESENCE
26.9.4 PRODUCT PORTFOLIO
26.9.5 RECENT DEVELOPMENTS
26.1 GRIFOLS S.A.
26.10.1 COMPANY OVERVIEW
26.10.2 REVENUE ANALYSIS
26.10.3 GEOGRAPHIC PRESENCE
26.10.4 PRODUCT PORTFOLIO
26.10.5 RECENT DEVELOPMENTS
26.11 HEBEI TIANCHENG PHARMACEUTICAL CO., LTD.
26.11.1 COMPANY OVERVIEW
26.11.2 REVENUE ANALYSIS
26.11.3 GEOGRAPHIC PRESENCE
26.11.4 PRODUCT PORTFOLIO
26.11.5 RECENT DEVELOPMENTS
26.12 GUIZHOU TIANDI PHARMACEUTICAL CO., LTD.
26.12.1 COMPANY OVERVIEW
26.12.2 REVENUE ANALYSIS
26.12.3 GEOGRAPHIC PRESENCE
26.12.4 PRODUCT PORTFOLIO
26.12.5 RECENT DEVELOPMENTS
26.13 ALTHEA
26.13.1 COMPANY OVERVIEW
26.13.2 REVENUE ANALYSIS
26.13.3 GEOGRAPHIC PRESENCE
26.13.4 PRODUCT PORTFOLIO
26.13.5 RECENT DEVELOPMENTS
26.14 PFIZER
26.14.1 COMPANY OVERVIEW
26.14.2 REVENUE ANALYSIS
26.14.3 GEOGRAPHIC PRESENCE
26.14.4 PRODUCT PORTFOLIO
26.14.5 RECENT DEVELOPMENTS
27 RELATED REPORTS
28 CONCLUSION
29 QUESTIONNAIRE
30 ABOUT DATA BRIDGE MARKET RESEARCH
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.